Effects of 12 weeks’ treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study
暂无分享,去创建一个
J. Rehfeld | A. Vaag | J. Petersen | P. Rossing | A. Karlsen | K. Færch | S. Lund | C. Brøns | K. D. Hove